SEATTLE, March 14, 2023 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. SANAa company focused on the development and delivery of genetically engineered cells as medicines, announced today that four abstracts, including a late-breaking abstract highlighting preclinical data from both the hypoimmune and fusogen platforms, have been submitted for the poster presentation was accepted at the American Association for Cancer Research 2023 (AACR) Annual Meeting being held April 14-19, 2023 in Orlando, FL.
Current poster details:
| Title: | Increased potency of CD8-targeting fusosomes enhances delivery of the CAR gene to quiescent primary T cells |
| Session title: | Latest Research: Experimental and Molecular Therapeutics 3 |
| Session date: | Wednesday April 19, 2023 |
| session time: | 9:00am – 12:30pm ET |
| Location: | Poster section 35 |
| Abstract number: | LB311 |
Poster details:
| Title: | Modulation of quiescent T-cell status to enhance transduction and CAR-T expansion after exposure to CD8-targeted fusosomes |
| Session Category: | Experimental and molecular therapeutics |
| Session title: | Gene and vector based therapy |
| Session date: | Monday 17 April 2023 |
| session time: | 1:30 p.m. – 5:00 p.m. ET |
| Location: | Poster section 16 |
| Abstract number: | 2734 |
| Title: | Development of a novel, fully human chimeric antigen receptor for anti-CD19 in vivo Delivery via CD8-directed fusosome |
| Session Category: | Experimental and molecular therapeutics |
| Session title: | Gene and vector based therapy |
| Session date: | Monday 17 April 2023 |
| session time: | 1:30 p.m. – 5:00 p.m. ET |
| Location: | Poster section 16 |
| Abstract number: | 2735 |
| Title: | Genetically engineered hypoimmune CAR-T cells provide durable tumor control in immunocompetent allogeneic humanized mice, even when challenged |
| Session category: | immunology |
| Session title: | CAR T cell therapy 2 |
| Session date: | Tuesday April 18, 2023 |
| session time: | 9:00am – 12:30pm ET |
| Location: | Poster section 23 |
| Abstract number: | 4091 |
Complete regular abstracts and current abstract titles can be viewed via the AACR online route planner located here:…
[ad_2]
Source story
